Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Lymphomes non hodgkinien
- | Specialty :
- Thérapies Ciblées
Extract
An open-label, single-arm. multi-center phase 2 trial with ofatumumab in patients with relapsed diffuse large B-cell lymphoma (DLBCL) ineligible for transplant or relapsed after autologous transplant.
Scientific Abstract
en cours d'intégration;